Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Patient Comfort and Antimicrobial Efficacy With Aqueous Chlorhexidine Versus Povidine-Iodine (Betadine) as Ocular Surface Disinfectant Prior to Intravitreal Injection

NCT03571100 is registered in ClinicalTrials.gov with MidAtlantic Retina as lead sponsor.

NCT NCT03571100
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03571100 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Patient Comfort and Antimicrobial Efficacy With Aqueous Chlorhexidine Versus Povidine-Iodine (Betadine) as Ocular Surface Disinfectant Prior to Intravitreal Injection
Lead sponsor
MidAtlantic Retina
Phase
Phase 1
Overall status
Unknown status
Start date
May 7, 2018
Completion date
May 6, 2019
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, diabetic vascular diseases, proliferative retinopathy, retina vein occlusion